Savara
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Savara and other ETFs, options, and stocks.About SVRA
Savara, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of novel therapies for the treatment of serious or life-threatening rare respiratory diseases. Its program includes molgramostim, which is an inhaled formulation of recombinant human GM-CSF and being developed for the treatment of autoimmune pulmonary alveolar proteinosis.
SVRA Key Statistics
Stock Snapshot
With a market cap of 1.09B, Savara(SVRA) trades at $5.24. The stock has a price-to-earnings ratio of -9.49.
On 2026-06-16, Savara(SVRA) stock traded between a low of $5.20 and a high of $5.40. Shares are currently priced at $5.24, which is +0.7% above the low and -2.9% below the high.
Savara(SVRA) shares are trading with a volume of 967.12K, against a daily average of 1.51M.
During the past year, Savara(SVRA) stock moved between $1.98 at its lowest and $7.01 at its peak.
During the past year, Savara(SVRA) stock moved between $1.98 at its lowest and $7.01 at its peak.
SVRA News
Savara (SVRA) is back in focus after announcing that Chief Financial and Administrative Officer Dave Lowrance will step down for health reasons. Chief Operating...
Earlier this month, Savara Inc. stockholders approved an amendment to double the company’s authorized common shares from 300,000,000 to 600,000,000, while Chief...
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.